However, this approach has also impacted Type 2 diabetes patients access to GLP-1s by requiring some patients to try other diabetes treatments (e.g., blood sugar regulators such as sodium-glucose cotransporter-2 inhibitor Brenzavvy and dipeptidyl peptidase-4 inhibitor Onglyza) before GLP-1 approval
RGC-5 cells were incubated with different concentrations of glucose (25, 40, 65, 80, 95, and 110 nmol/L)
Please note that the FDA does not review or approve compounded medications for safety or efficacy
Although a good GLP-1 diet plan will vary on an individual basis, its important for everyone taking these medications to maintain baseline targets of fiber, protein and daily calories
Address stress through sleep optimization and relaxation techniques